Clinical Trial: Safety and Efficacy of the Fully Closed Loop iLet Bionic Pancreas in Adults With Type 1 and Type 2 Diabetes

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911566) titled 'Safety and Efficacy of the Fully Closed Loop iLet Bionic Pancreas in Adults With Type 1 and Type 2 Diabetes' on Oct. 27.

Brief Summary: The goal of this clinical trial is to evaluate the safety and efficacy of the fully closed loop (FCL) iLet automated insulin delivery (AID) System in people >=18 years old with type 1 diabetes or type 2 diabetes requiring insulin therapy. The main questions it aims to answer are:

Do HbA1c levels decrease when using the iLet FCL algorithm?

What medical problems do participants have when using the iLet FCL algorithm?

Participants will use the iLet FCL for 13 weeks, undergo bloodwork, and complete ps...